🇺🇸 AMDINOCILLIN PIVOXIL in United States

236 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 38 reports (16.1%)
  2. Sepsis — 28 reports (11.86%)
  3. Constipation — 27 reports (11.44%)
  4. Blood Creatinine Increased — 26 reports (11.02%)
  5. Hydronephrosis — 24 reports (10.17%)
  6. Diarrhoea — 23 reports (9.75%)
  7. Cytomegalovirus Infection — 19 reports (8.05%)
  8. Off Label Use — 18 reports (7.63%)
  9. Vomiting — 17 reports (7.2%)
  10. Dizziness — 16 reports (6.78%)

Source database →

AMDINOCILLIN PIVOXIL in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is AMDINOCILLIN PIVOXIL approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for AMDINOCILLIN PIVOXIL in United States?

Marketing authorisation holder not available in our data.